KMB vs SLRX · P/E 19, rev $8.35B vs $4.9M cap
Kimberly-Clark Corporation (KMB) versus Salarius Pharmaceuticals Inc (SLRX) — a side-by-side from cached financials, not a winner call.
Kimberly-Clark Corporation (KMB) is a household & personal products company listed on US.
Salarius Pharmaceuticals Inc (SLRX) is a biotechnology company listed on NASDAQ.
Latest reported KMB revenue for 2026-06-30 was $8.35B. Net income was $1.01B. KMB currently screens at market cap $32.88B and trailing P/E 19.2.
Latest reported SLRX revenue for 2023-03-31 was $0. Net income was -$5.3M. SLRX currently screens at market cap $4.9M.
KMB currently screens at market cap $32.88B and trailing P/E 19.2. SLRX currently screens at market cap $4.9M.
Not investment advice. Open the KMB and SLRX stock pages for the full models.
Not investment advice.